Cibc World Market Inc. Abb Vie Inc. Transaction History

Cibc World Market Inc.

$43.4 Billion
Q2 2024

A detailed history of Cibc World Market Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Cibc World Market Inc. holds 530,331 shares of ABBV stock, worth $102 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

530,331

Previous 542,865 2.31%

Holding current value

$102 Million

Previous $98.9 Million 7.99%

% of portfolio

0.21%

Previous 0.23%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$154.79 - $180.76 $1.94 Million - $2.27 Million	-12,534 Reduced 2.31%	530,331 $91 Million
Q1 2024 May 13, 2024	SELL	$159.82 - $182.1 $1.38 Million - $1.58 Million	-8,651 Reduced 1.57%	542,865 $98.9 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $5.59 Million - $6.3 Million	-40,656 Reduced 6.87%	551,516 $85.5 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $7.25 Million - $8.4 Million	-54,299 Reduced 8.4%	592,172 $88.3 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $6.7 Million - $8.34 Million	-50,566 Reduced 7.25%	646,471 $87.1 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $12.6 Million - $14.5 Million	-86,845 Reduced 11.08%	697,037 $111 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $3.87 Million - $4.65 Million	-28,012 Reduced 3.45%	783,882 $127 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $11.8 Million - $13.5 Million	-87,969 Reduced 9.78%	811,894 $109 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $152,345 - $193,680	-1,107 Reduced 0.12%	899,863 $138 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $1.76 Million - $2.18 Million	-13,301 Reduced 1.45%	900,970 $146 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $7.73 Million - $9.78 Million	71,938 Added 8.54%	914,271 $124 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $4.15 Million - $4.71 Million	38,961 Added 4.85%	842,333 $90.9 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $4.43 Million - $4.93 Million	42,069 Added 5.53%	803,372 $90.5 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $24.7 Million - $27.2 Million	241,596 Added 46.49%	761,303 $82.4 Million
Q4 2020 Feb 08, 2021	BUY	$80.49 - $108.67 $3.95 Million - $5.34 Million	49,121 Added 10.44%	519,707 $55.7 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $777,485 - $912,511	9,050 Added 1.96%	470,586 $41.2 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $2.87 Million - $3.84 Million	39,152 Added 9.27%	461,536 $45.3 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $3.9 Million - $5.91 Million	60,459 Added 16.7%	422,384 $32.2 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $1.36 Million - $1.7 Million	18,808 Added 5.48%	361,925 $32 Million
Q3 2019 Nov 13, 2019	SELL	$62.98 - $75.72 $4.81 Million - $5.78 Million	-76,382 Reduced 18.21%	343,117 $26 Million
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $715,473 - $914,542	10,890 Added 2.67%	419,499 $30.5 Million
Q1 2019 May 09, 2019	BUY	$77.14 - $90.79 $3.4 Million - $4.01 Million	44,132 Added 12.11%	408,609 $32.9 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $8.3 Million - $10.2 Million	-106,658 Reduced 22.64%	364,477 $33.6 Million
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $55.5 Million - $61.7 Million	-624,484 Reduced 57.0%	471,135 $44.6 Million
Q2 2018 Aug 08, 2018	BUY	$89.78 - $106.23 $51.1 Million - $60.5 Million	569,237 Added 108.14%	1,095,619 $102 Million
Q1 2018 May 18, 2018	BUY	$92.01 - $123.21 $19.5 Million - $26.1 Million	211,811 Added 67.33%	526,382 $49.8 Million
Q4 2017 Feb 01, 2018	SELL	$89.56 - $98.21 $1.04 Million - $1.14 Million	-11,633 Reduced 3.57%	314,571 $30.4 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $22.8 Million - $29.1 Million	326,204	326,204 $29 Million

Others Institutions Holding ABBV

# of Institutions

3,693

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $341B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Account

Cibc World Market Inc. Abb Vie Inc. Transaction History